Evidence map›Paper›PMID 36457522›Full record

ArticleFrontiers in plant science2022

Polyphenolics, glucosinolates and isothiocyanates profiling of aerial parts of

Sotiris Kyriakou, Kyriaki Michailidou, Tom Amery, Kyle Stewart, Paul G Winyard, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis

Abstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. UntargetedNutrients · 2026
    Trial
  3. Urease Inhibitors fromACS pharmacology & translational science · 2026
    Article
  4. Efficacy of Watercress (Antioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Watercress (Life (Basel, Switzerland) · 2025
    Review
  9. Impacts of Sulfur on Glucosinolate Metabolism: FromPlants (Basel, Switzerland) · 2025
    Review
  10. Review
  11. Evaluating the Chemical Composition and Antitumor Activity ofInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sotiris KyriakouDepartment of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
Kyriaki MichailidouBiostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
Tom AmeryThe Watercress Company, Dorchester, United Kingdom.
Kyle StewartWatercress Research Limited, Devon, United Kingdom.
Paul G WinyardWatercress Research Limited, Devon, United Kingdom.
Dimitrios T TrafalisLaboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
Rodrigo FrancoRedox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE, United States.
Aglaia PappaDepartment of Molecular Biology & Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Mihalis I PanayiotidisDepartment of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Watercress (

Indexed as

flavonoidsglucosinolatesisothiocyanatespolyphenolic acidsthiourea derivativesUPLC-ESI-MS/MSwatercress

Identifiers

PMID36457522
PMCPMC9706002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.